TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Little Green Pharma Ltd. ( (AU:LGP) ).
Little Green Pharma Ltd has announced the quotation of 105,000 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of July 15, 2025. This move is part of the company’s strategy to enhance its market presence and potentially increase liquidity for its securities, which could have implications for its stakeholders and overall market positioning.
The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.21 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd operates in the pharmaceutical industry, focusing on the production and distribution of medical cannabis products. The company is involved in cultivating and manufacturing cannabis-based medicines, targeting markets where medical cannabis is legally approved.
Average Trading Volume: 104,194
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$31.92M
Find detailed analytics on LGP stock on TipRanks’ Stock Analysis page.